Iranian Journal of War and Public Health

eISSN (English): 2980-969X
eISSN (Persian): 2008-2630
pISSN (Persian): 2008-2622
0.5
JMERC
Volume 17, Issue 3 (2025)                   3 2025, 17(3): 319-323 | Back to browse issues page

Print XML PDF HTML Full-Text (HTML)


History

How to cite this article
NagaRaju D, Subramanian S, Koganti V, Shekhar S, Himabindu K, Alagesan J, et al . Persistent Musculoskeletal, Cardiopulmonary, Neurological, and Psychiatric Symptoms Among COVID-19 Survivors. 3 2025; 17 (3) :319-323
URL: http://ijwph.daneshafarand.org/article-3-85643-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
1- Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, Chennai, India
2- Department of Physiotherapy, Nimra Institute of Medical Sciences, Jupudi, India
3- Department of Physiotherapy, Faculty of Cardio Physiotherapy., KNR University of Health Sciences, Hyderabad, India
4- Department of Physiotherapy, School of Health Sciences, Apollo University, Murukampattu, India
5- Department of Physiotherapy, School of Paramedical, Mohan Babu University, Tirupati, India
* Corresponding Author Address: Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, Chennai, India. (subramanian.scpt@saveetha.com)
Abstract   (801 Views)
Aims: The COVID-19 pandemic has affected numerous survivors who experience ongoing symptoms impacting various body systems. This study aimed to investigate the prevalence and persistence of musculoskeletal, cardiopulmonary, neurological, and psychiatric symptoms among COVID-19 survivors who attended NRI General Hospital in Andhra Pradesh, India.
Instrument & Methods: This cross-sectional survey was conducted from February 2023 to February 2024 at NRI General Hospital in Andhra Pradesh, India. A total of 119 COVID-19 survivors under the age of 55 were enrolled. Participants reported the presence and duration of musculoskeletal, cardiopulmonary, neurological, and psychiatric symptoms persisting for at least three months post-recovery.
Findings: Musculoskeletal symptoms were the most prevalent, with muscle pain (48.7%) and fatigue (44.5%) reported most frequently, followed by joint pain (33.6%). Cardiopulmonary symptoms, such as dyspnea (27.7%), typically resolved within six to twelve months. Neurological complaints, including concentration difficulties (22.7%) and headaches (19.3%), persisted longer in some participants. Psychiatric manifestations, such as anxiety and depression, were reported by 15.9% and 12.6% of the cohort, respectively. Analytical correlation revealed significant overlap between the durations of musculoskeletal and neurological symptoms (p<0.05).
Conclusion: Musculoskeletal symptoms represent the most common and long-lasting complications among COVID-19 survivors.
 
Keywords: